Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

NCT02500511 · clinicaltrials.gov ↗

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis
Meningococcal Infections

Interventions

BIOLOGICAL: NmVac4-A/C/Y/W-135-DT™

Sponsor

JN-International Medical Corporation